Clinical Laserthermia Systems AB (CLS B) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 63.27%, its profits have risen by 37.3%

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 241 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.24

Return on Equity

-64.37%

Price to Book

3.58

Revenue and Profits:

Net Sales:

9 Million

(Quarterly Results - Jun 2025)

Net Profit:

-6 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-14.19%

6 Months

156.25%

1 Year

63.27%

2 Years

-73.21%

3 Years

811.11%

4 Years

75.71%

5 Years

17.52%

Clinical Laserthermia Systems AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

71.28%

EBIT Growth (5y)

6.09%

EBIT to Interest (avg)

-28.36

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.38

Sales to Capital Employed (avg)

0.28

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.06

EV to EBIT

-5.40

EV to EBITDA

-5.84

EV to Capital Employed

3.71

EV to Sales

7.95

PEG Ratio

Dividend Yield

ROCE (Latest)

-68.65%

ROE (Latest)

-64.37%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 67.86% vs 330.77% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 53.68% vs 17.58% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.40",
          "val2": "5.60",
          "chgp": "67.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-12.30",
          "chgp": "81.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.30",
          "val2": "-13.60",
          "chgp": "53.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-305.30%",
          "val2": "-2,299.00%",
          "chgp": "199.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 126.51% vs 31.75% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 40.79% vs -13.46% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.80",
          "val2": "8.30",
          "chgp": "126.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-51.60",
          "val2": "-63.10",
          "chgp": "18.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "9.80",
          "chgp": "-95.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-47.90",
          "val2": "-80.90",
          "chgp": "40.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,890.50%",
          "val2": "-7,957.90%",
          "chgp": "506.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

9.40

5.60

67.86%

Operating Profit (PBDIT) excl Other Income

-2.30

-12.30

81.30%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-6.30

-13.60

53.68%

Operating Profit Margin (Excl OI)

-305.30%

-2,299.00%

199.37%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 67.86% vs 330.77% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 53.68% vs 17.58% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

18.80

8.30

126.51%

Operating Profit (PBDIT) excl Other Income

-51.60

-63.10

18.23%

Interest

0.40

9.80

-95.92%

Exceptional Items

0.00

Consolidate Net Profit

-47.90

-80.90

40.79%

Operating Profit Margin (Excl OI)

-2,890.50%

-7,957.90%

506.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 126.51% vs 31.75% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 40.79% vs -13.46% in Dec 2023

All Annual Results

Company CV

About Clinical Laserthermia Systems AB

Clinical Laserthermia Systems AB

Pharmaceuticals & Biotechnology

Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT). imILT method can be used for all tumors in solid organ and the potential market is considerable. Examples of tumors which are suitable for treatment are those found in liver, breast, lung, prostate, kidney, pancreas and thyroid. Clinical Laserthermia Systems AB's treatment system consists of two main parts: a mobile laser device and a sterile patient unit for single use. The Company's product is intended for medical professionals within surgical oncology or interventional radiology within oncology. In April 2014, the Company announced the establishment of a subsidiary in the United States.

Company Coordinates

Company Details

Medicon Village, Scheelevagen 2 , LUND None : 223 81

Tel: 46 46 152100

https://clinicallaser.se/

Registrar Details